T cell receptor excision circles and HIV-1 2-LTR episomal DNA to predict AIDS in patients not receiving effective therapy

被引:14
|
作者
Goedert, JJ [1 ]
O'Brien, TR
Hatzakis, A
Kostrikis, LG
机构
[1] NCI, Viral Epidemiol Branch, Div Canc Epidemiol & Genet, Rockville, MD USA
[2] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10021 USA
[3] Univ Athens, Sch Med, Dept Hyg & Epidemiol, Natl Retrovirus Reference Ctr, GR-11527 Athens, Greece
关键词
AIDS incidence; prospective cohort study; hemophilia; T-cell production; HIV-1; replication;
D O I
10.1097/00002030-200111230-00005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To determine whether improved prediction of AIDS-free survival following HIV-1 seroconversion is achieved by measuring HIV-1 2-LTR episomal DNA (2-LTR) circles and T cell receptor rearrangement excision circles (TREC), reflecting HIV replication and lymphocyte emigration from the thymus, respectively. Design: Subanalysis of a cohort of 154 patients with hemophilia who became HIV positive between 1978 and 1985 and were followed prospectively. Methods: Relative hazards (RH) of AIDS, in the absence of highly effective anti-HIV therapy, were estimated for age, HIV-1 viral load, CD4 lymphocyte count and levels of HIV-1 2-LTR circles and TREC [per 10(6) peripheral blood mononuclear cells (PBMC)] Results: TREC correlated significantly with CD4 cell counts (r = 0.30) and age (r = -0.60). 2-LTR circles correlated significantly with HIV-1 viral load (r = 0.35). If viral load, CD4 lymphocytes and age were included in a proportional hazards model, the risk of AIDS during a median of 11.6 years of follow-up was increased significantly with fewer TREC (adjusted RH, 2.0 per log(10) copies/10(6) PBMC) and more 2-LTR circles (RH, 1.7 per log(10) copies/10(6) PBMC). AIDS prediction with TREC and 2-LTR circles held for most subgroups defined by median viral load, CD4 lymphocytes and age. Conclusions: PBMC that have high levels of HIV-1 replication and low levels of recent thymic emigrants are associated with a substantially increased risk of AIDS. It is not known if measurement of either TREC or 2-LTR circles will complement HIV-11 viral load as an estimation of the risk of AIDS for patients who are receiving highly effective anti-HIV therapy. (C) 2001 Lippincott Williams Wilkins.
引用
收藏
页码:2245 / 2250
页数:6
相关论文
共 50 条
  • [31] Impact of HIV-1 tropism on the emergence of non-AIDS events in HIV-infected patients receiving fully suppressive antiretroviral therapy
    Maffongelli, Gaetano
    Alteri, Claudia
    Gentilotti, Elisa
    Bertoli, Ada
    Ricciardi, Alessandra
    Malagnino, Vincenzo
    Svicher, Valentina
    Santoro, Maria M.
    Dori, Luca
    Perno, Carlo F.
    Andreoni, Massimo
    Sarmati, Loredana
    AIDS, 2016, 30 (05) : 731 - 741
  • [32] Evaluation of HIV-DNA, soluble CD14 and inflammatory markers in HIV-1 positive patients receiving antiretroviral therapy
    Turriziani, Ombretta
    Falasca, Francesca
    Bon, Isabella
    Mazzuti, Laura
    Tranquilli, Giulia
    Mezzaroma, Ivano
    D'Ettorre, Gabriella
    Bucci, Mauro
    Re, Maria Carla
    Vullo, Vincenzo
    Antonelli, Guido
    JOURNAL OF CLINICAL VIROLOGY, 2016, 82 : S8 - S8
  • [33] T cell recognition of autologous and non-autologous HIV-1 protease peptides by HIV-1 infected patients undergoing PI therapy
    Moraes, S. L.
    Muller, N. G.
    Paula, M. O.
    Arruda, M. B.
    Brindeiro, R. M.
    Alencar, R.
    Jamal, L.
    Kalil, J.
    Cunha-Neto, E.
    RETROVIROLOGY, 2009, 6
  • [34] Learning from HIV-1 to predict the immunogenicity of T cell epitopes in SARS-CoV-2
    Gao, Ang
    Chen, Zhilin
    Amitai, Assaf
    Doelger, Julia
    Mallajosyula, Vamsee
    Sundquist, Emily
    Segal, Florencia Pereyra
    Carrington, Mary
    Davis, Mark M.
    Streeck, Hendrik
    Chakraborty, Arup K.
    Julg, Boris
    ISCIENCE, 2021, 24 (04)
  • [35] Dynamics of HIV-1 DNA level in highly antiretroviral-experienced patients receiving raltegravir-based therapy
    Charpentier, C.
    Piketty, C.
    Laureillard, D.
    Tisserand, P.
    Si-Mohamed, A.
    Weiss, L.
    Belec, L.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2012, 31 (02) : 129 - 133
  • [36] Dynamics of HIV-1 DNA level in highly antiretroviral-experienced patients receiving raltegravir-based therapy
    C. Charpentier
    C. Piketty
    D. Laureillard
    P. Tisserand
    A. Si-Mohamed
    L. Weiss
    L. Bélec
    European Journal of Clinical Microbiology & Infectious Diseases, 2012, 31 : 129 - 133
  • [37] Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection
    Mette D. Hazenberg
    Sigrid A. Otto
    James W.T. Cohen Stuart
    Martie C.M. Verschuren
    Jan C.C. Borleffs
    Charles A.B. Boucher
    Roel A. Coutinho
    Joep M.A. Lange
    Tobias F. Rinke de Wit
    Aster Tsegaye
    Jacques J.M. van Dongen
    Dörte Hamann
    Rob J. de Boer
    Frank Miedema
    Nature Medicine, 2000, 6 : 1036 - 1042
  • [38] Persistent high levels of immune activation and correlations with HIV-1 proviral DNA and 2-LTR circle loads in a cohort of Mexican individuals following long-term and fully suppressive treatment
    Orta-Resendiz, Aurelio
    Viveros-Rogel, Monica
    Fuentes-Romero, Luis L.
    Vergara-Mendoza, Moises
    Romero-Rodriguez, Damaris P.
    Munoz-Lopez, Monica
    Zancatl-Diaz, Martha L.
    Vidal-Laurencio, Elsa Y.
    Rodriguez-Diaz, Roberto A.
    Soto-Ramirez, Luis E.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 100 : 184 - 192
  • [39] Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection
    Hazenberg, MD
    Otto, SA
    Stuart, JWTC
    Verschuren, MCM
    Borleffs, JCC
    Boucher, CAB
    Coutinho, RA
    Lange, JMA
    De Wit, TFR
    Tsegaye, A
    Van Dongen, JJM
    Hamann, D
    De Boer, RJ
    Miedema, F
    NATURE MEDICINE, 2000, 6 (09) : 1036 - 1042
  • [40] Hepatitis C therapy with interferon-α and ribavirin reduces the CD4 cell count and the total, 2LTR circular and integrated HIV-1 DNA in HIV/HCV co-infected patients
    Jiao, Yan-mei
    Weng, Wen-jia
    Gao, Quan-sheng
    Zhu, Wei-jun
    Cai, Wei-ping
    Li, Ling-hua
    Li, Hong-jun
    Gao, Yan-qing
    Wu, Hao
    ANTIVIRAL RESEARCH, 2015, 118 : 118 - 122